SKYE
Skye Bioscience, Inc.
1.70$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 33.0% | 38.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 67.0% | 61.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 39.2% | 35.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 41.7% | 63.5% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 25.3% | -2.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.9% | 0.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 29.3% | -1.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.5% | -1.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 27.8% | -35.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 29.3% | 2.7% | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.